# Weight-loss drug could help address nighttime sleep disruptions for millions

- URL: https://talkfuse.com/story/weight-loss-drug-could-help-address-nighttime-sleep-disruptions-for-millions/
- Published: 2026-10-28T11:00:59+00:00
- Updated: 2026-10-28T11:39:35+00:00
- Original publisher: Fox News (publisher lean: Far right)
- Original article: https://www.foxnews.com/health/weight-loss-drug-help-address-nighttime-sleep-disruptions-millions
- Topics: Health, Medicine, World

## Key points

- Retatrutide reduced sleep apnoea symptoms in two trials.
- Participants lost up to nearly 20% of their body weight.
- The experimental drug is not FDA-approved.

## Summary

Two phase 3 trials found that the experimental weight-loss drug retatrutide reduced breathing interruptions and other symptoms of obstructive sleep apnoea in adults who were overweight or obese. The findings could matter because the condition is common, often undiagnosed and linked to higher cardiovascular risks, though the results do not establish that the drug prevents heart problems.

The trials included 691 adults with moderate-to-severe sleep apnoea, who received weekly retatrutide injections or a placebo for 80 weeks. Participants taking the drug lost 12% to nearly 20% of their body weight; around 68% had more than a 50% improvement in symptoms, and low-oxygen burden fell by about 65% to 75%. Retatrutide is not approved by the FDA, and researchers said further work is needed on long-term cardiovascular effects.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.